Xtant Medical Holdings Inc (XTNT)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $38.12M
Last updated: Nov 17, 2026 at 4:10 PM ET
Xtant Medical Holdings Inc (XTNT) Statistics
Xtant Medical Holdings (XTNT) has a market cap of $38.12M and an enterprise value of $52.36M. Revenue fell 24.44% over the last 12 months from the 12 months before. It kept -15.92% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 37.38% above the market cap, as debt exceeds cash.
| Market Cap | $38.12M |
|---|---|
| Enterprise Value | $52.36M |
| Latest price (Nov 17, 2026) | $0.20 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 0.8x. Its year-end P/S ranged from 0.1x to 1.5x from 2017 to 2025.
| P/S Ratio | 0.3x |
|---|---|
| Forward P/S | 0.4x |
| P/B Ratio | 0.8x |
| P/TBV Ratio | 0.9x |
Price Statistics
The stock is down 68.93% over 52 weeks and trades 35.48% below its 50-day average.
| Beta (1Y) | 0.58 |
|---|---|
| 52-Week Change | -68.93% |
| 1-Month Change | -30.38% |
| 3-Month Change | -38.62% |
| 6-Month Change | -55.86% |
| 5-Year Change | -75.63% |
| 10-Year Change | -96.89% |
| Total Return (1Y) | -68.93% |
| Total Return (3Y CAGR) | -43.93% |
| Max Drawdown (1Y) | -74.99% |
| Max Drawdown (3Y) | -85.42% |
| Sharpe Ratio (1Y) | -1.69 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $0.31 |
| 200-Day Average | $0.44 |
| 52-Week Range | $0.17 to $0.84 |
| RSI (14 Days) | 22.2 |
| Average Volume (20 Days) | 230.03K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.00x current liabilities, and total debt is 0.59x shareholder equity.
| Current Ratio | 2.00x |
|---|---|
| Quick Ratio | 0.93x |
| Debt / Equity | 0.59x |
| Interest Coverage | 2.88x |
Returns and Efficiency
Return on invested capital is -20.35% over the last 12 months, against a 5-year average of -4.90%.
| Return on Equity (ROE) | -42.96% |
|---|---|
| Return on Assets (ROA) | -21.28% |
| Return on Invested Capital (ROIC) | -20.35% |
| Return on Capital Employed (ROCE) | -26.84% |
| ROE (5Y Average) | -13.55% |
| ROA (5Y Average) | -6.90% |
| ROIC (5Y Average) | -4.90% |
| Asset Turnover | 1.11x |
| Inventory Turnover | 1.33x |
| Receivables Turnover | 5.26x |
| Cash Conversion Cycle | 295 days |
Scores
XTNT has an Altman Z-Score of -3.29, in the distress zone below 1.81, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -3.29 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue was $100.56M over the last 12 months.
| Revenue | $100.56M |
|---|---|
| Revenue Growth (YoY) | -24.44% |
| Gross Profit | $56.72M |
| Operating Income | -$16.06M |
| Pretax Income | -$14.20M |
| Net Income | -$16.01M |
| EBITDA | -$8.72M |
| EBIT | -$12.07M |
| Reported EPS (TTM) | -$0.12 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 49.53% of the $75.22M in total assets.
| Cash and Equivalents | $7.79M |
|---|---|
| Total Debt | $22.04M |
| Net Debt | $14.25M |
| Net Debt Per Share | $0.10 |
| Working Capital | $30.33M |
| Shareholder Equity | $37.26M |
| Book Value Per Share | $0.27 |
| Tangible Book Value | $30.96M |
| Tangible Book Per Share | $0.22 |
| Total Assets | $75.22M |
| Total Liabilities | $37.96M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.23M of capital spending, operating cash flow left -$6.12M of free cash flow.
| Operating Cash Flow | -$4.90M |
|---|---|
| Capital Expenditures | $1.23M |
| Free Cash Flow | -$6.12M |
| FCF Per Share | -$0.04 |
| Depreciation and Amortization | $3.34M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -15.98%, against a 5-year average of -6.92%.
| Gross Margin | 56.40% |
|---|---|
| Operating Margin | -15.98% |
| Pretax Margin | -14.12% |
| Net Margin | -15.92% |
| EBITDA Margin | -8.67% |
| EBIT Margin | -12.00% |
| FCF Margin | -6.09% |
| Gross Margin (5Y Average) | 59.22% |
| Operating Margin (5Y Average) | -6.92% |
| Net Margin (5Y Average) | -6.60% |
Growth
Revenue grew 32.20% a year over 3 years.
| Revenue Growth (3Y CAGR) | +32.20% |
|---|---|
| Revenue Growth (5Y CAGR) | +20.22% |
| Book Value Per Share Growth (2Y CAGR) | -7.34% |
| Tangible Book Per Share Growth (2Y CAGR) | +6.57% |
Dividends and Yields
XTNT does not pay a dividend. Its free cash flow yield is -21.53%.
| FCF Yield | -21.53% |
|---|---|
| Buyback Yield | 0.23% |
| Shareholder Yield | 0.23% |
Stock Splits
The last split was a 1-for-12 reverse split on Feb 14, 2018.
| Last Split Date | Feb 14, 2018 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Peer Position
Against 12 similar companies, XTNT has the 12th highest P/S.
P/S RatioPeer median 1.8x
ROICPeer median -77.64%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.27%
| P/S Ratio | 0.3x vs 1.8x median |
|---|---|
| ROIC | -20.35% vs -77.64% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -24.44% vs +9.27% median |
Analyst Forecast
Consensus estimates put revenue growth at -9.28% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -9.28% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About XTNT
What is XTNT's market cap?
Xtant Medical Holdings has a market cap of $38.12M. Its enterprise value, which adds debt and subtracts cash, is $52.36M.
How many shares of XTNT are outstanding?
Xtant Medical Holdings has 140.36M shares outstanding. The count is up 0.47% from a year earlier.
Does XTNT pay a dividend?
No. Xtant Medical Holdings does not pay a dividend.
How much debt does XTNT have?
Xtant Medical Holdings has $22.04M of total debt and $7.79M of cash and equivalents, a net debt position of $14.25M.
XTNT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors